Document 0916 DOCN M9540916 TI Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients. DT 9504 AU Sardar AM; Bell JE; Reynolds GP; Department of Biomedical Science, University of Sheffield,; England, UK. SO J Neurochem. 1995 Feb;64(2):932-5. Unique Identifier : AIDSLINE MED/95131220 AB Human immunodeficiency virus (HIV)-1-associated dementia is a frequent consequence of HIV infection and is associated with neuronal deficits. Increased concentrations of the kynurenine pathway metabolites 3-hydroxykynurenine (3-HK) and quinolinic acid (QA) may contribute to this neuronal damage. We measured 3-HK concentrations and the activity of its catabolising enzyme, 3-hydroxykynureninase, in postmortem brain tissue from eight controls and 32 HIV-positive patients, including a group that exhibited dementia. 3-HK concentrations were significantly increased (over threefold) in the HIV-positive group when compared with controls. This increase was greater in those patients with dementia, but it was still apparent in the nondemented cases. 3-Hydroxykynureninase activity was significantly increased in the HIV-infected group compared with the control values. The effect was apparent in both nondementia and dementia cases, although the latter showed a slightly greater increase. The 3-HK content increase is thus unrelated to a reduction in activity of this enzyme and is likely to reflect an overall increase in the kynurenic metabolic pathway. Elevated levels of the neurotoxin 3-HK may contribute to the neuronal deficits underlying HIV-associated dementia. DE Adult AIDS Dementia Complex/METABOLISM Female Frontal Lobe/*METABOLISM Human HIV Seropositivity/*METABOLISM HIV-1/*IMMUNOLOGY Kynurenine/*ANALOGS & DERIVATIVES/METABOLISM Male Neurotoxins/*METABOLISM Osmolar Concentration Reference Values Support, Non-U.S. Gov't JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).